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Recent studies have demonstrated that formaldehyde (FA)—induced neurotoxicity is
important in the pathogenesis of Alzheimer’s disease (AD). Elevated levels of FA have
been associated with memory impairments and the main hallmarks of AD pathology,
including β-amyloid plaques, tau protein hyperphosphorylation, and neuronal loss.
Resveratrol (Res), as a polyphenol anti-oxidant, has been considered to have therapeutic
potential for the treatment of AD. However, it has not been elucidated whether Res can
exert its neuroprotective effects against FA-induced neuronal damages related to AD
pathology. To answer this question, the effects of Res were investigated on Neuro-2a
(N2a) cells prior to and after FA exposure. The experiments found that pre-treatment
with Res significantly decreased FA-induced cytotoxicity, reduced cell apoptosis rates,
and inhibited the hyperphosphorylation of tau protein at Thr181 in a dose-dependent
manner. Further tests revealed that this effect was associated with the suppression of
glycogen synthase kinase (GSK-3β) and calmodulin-dependent protein kinase II (CaMKII)
activities, both of which are important kinases for tau protein hyperphosphorylation. In
addition, Res was found to increase the activity of phosphoseryl/phosphothreonyl protein
phosphatase-2A (PP2A). In summary, these findings provide evidence that Res protects
N2a cells from FA-induced damages and suggests that inhibition of GSK-3β and CaMKII
and the activation of PP2A by Res protect against the hyperphosphorylation and/or
mediates the dephosphorylation of tau protein, respectively. These possible mechanisms
underlying the neuroprotective effects of Res against FA-induced damages provide
another perspective on AD treatment via inhibition of tau protein hyperhosphorylation.
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INTRODUCTION
Formaldehyde (FA), a highly reactive single carbon aldehyde
with the formula CH2O or HCHO, is widely distributed in
living organisms and environments He et al. (2010). Exposure
to FA is known to cause acute health problems, such as upper
respiratory illnesses, allergies, and possible death (Tang et al.,
2009). More recently, studies have focused on evaluating the
association between chronic exposure to FA and its neurotoxicity.
An increasing number of reports have revealed that excessive
exposure to FA can induce amyloid aggregation (Chen et al.,
2007; Rizak et al., 2014) and tau protein aggregation and
hyperphosphorylation in vitro and in vivo (Nie et al., 2007;
Lu et al., 2013). Rodent studies have shown that elevation of
endogenous FA can lead to memory impairments, tau protein
hyperphosphorylation and neuronal loss (Tong et al., 2011,
2013; Yang et al., 2014a). In our previous study with monkeys,
the neurotoxicity of FA, induced with the chronic exposure to
methanol, was also observed to form β -amyloid plaques and
cause memory impairments (Yang et al., 2014b). All of these
findings suggest that FA toxicity is related to the main hallmarks
of AD pathology. Moreover, data from clinical studies has also
found elevation of endogenous FA in urine from dementia
patients to be inversely correlated with cognitive impairments
(Tong et al., 2011). Similar elevated FA levels have also been
observed post-mortem in the hippocampus of AD patients (Tong
et al., 2011). This evidence collectively indicates that FA is closely
linked to AD pathology, which opens a whole new avenue for
Alzheimer’s research and drug development.
Resveratrol (Res), as a polyphenol anti-oxidant, has attracted
wide attention for its potential as a therapeutic agent in
preventing and treating AD (Tredici et al., 1999; Ranney and
Petro, 2009). It has been reported that Res at 10–100µM can
exert neuroprotective effects (Richard et al., 2011). In vivo
and in vitro experiments have shown that Res exerted its
neuroprotective effects on AD pathological markers through
a number of mechanisms, such as by promoting clearance of
abnormal Aβ peptides and the anti-amyloidogenic cleavage of
β-amyloid precursor protein (APP), as well as by reducing
oxidative stress (Marambaud et al., 2005; Huang et al.,
2011). Interestingly, Res has also been identified as a natural
formaldehyde capturer (Tyihák et al., 1998). Together, the above-
mentioned evidence suggests that the neuroprotective effects
of Res have potential to reduce AD pathology. However, it is
not clear whether Res can protect neurons from FA-induced
damages.
To answer this question, the protective effects of Res were
investigated in FA-treated N2a cells, a mouse neuroblastoma cell
line widely used to study neurotoxicity (LePage et al., 2005).
Then, the underlying mechanisms of this protection were further
explored.
MATERIALS AND METHODS
Reagents
Antibodies and dyes used for western blotting and/or
immunostaining were obtained from the following resources:
Anti-β-actin (ab6276), anti-PP2A (ab32141), anti-CaMKII
(ab52476), anti-GSK3β (Y216) (ab85305), Goat anti-Mouse/
Donkey anti-Rabbit IgG horseradish peroxidase (HRP)-
conjugated secondary antibodies (ab6789)/(ab6802) were
purchased from Abcam (Cambridge, UK); anti-total tau [Tau5,
a monoclonal antibody recognizing both phosphorylated and
non-phosphorylated tau (MAB361)] was purchased from Merck
Millipore (Massachusetts, U.S.A.); anti-phosphorylated tau at
Thr181 (pT181) (SAB11107) was purchased from Signalway
Antibody (Maryland, U.S.A.); anti-phosphorylated tau at Ser396
(pS396) (44752G) was purchased from Invitrogen (California,
U.S.A.); anti-GSK-3β (Ser9) (#9322) was purchased from
Cell Signaling Technology (Beverly, MA, U.S.A.); DAPI was
purchased from Roche (Switzerland); anti-tubulin antibody
(ab28035) was purchased from Abcam (U.S.A). Cy5-labeled
Donkey anti-Rabbit/Donkey anti-Mouse secondary antibodies
(711-175-152)/(715-175-150) were purchased from Jackson
ImmunoResearch (West Baltimore Pike, PA, U.S.A.).
Chemicals: Dulbecco’s Modified Eagle’s Medium
(DMEM)/F12 was purchased from Gibco (U.S.A.). Fetal
bovine serum (FBS) was purchased from Hyclone (U.S.A.).
The cell viability assay kit CCK8 was purchased from Dojindo
Laboratories (Japan). The Annexin-V/PI cell apoptosis assay
kit was purchased from KeyGen Biotech (China). Dimethyl
sulfoxide (DMSO) was purchased from Amresco (U.S.A.).
Trypsin was purchased from Life Technologies (U.S.A.).
RIPA cell lysis buffer, BCA protein assay kit and penicillin-
streptomycin solution were purchased from Beyotime (China).
PVDF transfer membrane and chemiluminescent HRP substrate
were purchased from Millipore (U.S.A.). Protease inhibitor
cocktail (G6521) for cell lysates was purchased from Promega
(U.S.A.). Methanol-free formaldehyde (16% w/v) was purchased
from Thermo Scientific (U.S.A.). Resveratrol standard was
purchased from Sigma (St. Louis, MO, U.S.A.) and was
first dissolved in 50% DMSO and then diluted to various
concentrations with culture medium immediately before use.
Other reagents, unless otherwise noted, were of analytical grade
and purchased from local distributors.
Cell Culture
The mouse neuroblastoma N2a cell line was purchased from
Kunming Institute of Zoology, Chinese Academy of Sciences
(Kunming, China). The cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM)/F12 medium supplemented
with 10% fetal bovine serum (FBS) and 1% Penicillin-
Streptomycin in 100-mm culture dishes. Cells were incubated in
a humidified incubator at 37◦C with 5% CO2.
Experimental Design
N2a cells were divided into the following groups: blank control
group (cells without any treatment) and vehicle control group
(0.025% DMSO pre-treatment + FA treatment); FA group
(FA applied at an appropriate concentration according to each
experimental scale); Res group (Res applied at an appropriate
concentration according to each experimental scale); and Res
+ FA group (Res pre-, simultaneous-, and post-treatment
were performed according to each experimental scale). Cell
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viability, morphological changes and apoptosis rates were used
to evaluate cytotoxicity. Expression levels of tau protein and
candidate enzymes were measured by western blotting and
immunofluorescence assays.
A FA concentration of 0.35mM was selected to evaluate
the timing of Res administration (pre-, simultaneous-, or post-
treatments) because it was the LD50 of FA in N2a cells found
in preliminary studies (Figure 1A). In the western blotting
and apoptosis studies, the concentration of FA was increased
to 0.5mM because this FA concentration had been shown to
cause marked hyperphosphorylation of Tau protein in N2a cells
(Lu et al., 2011; Tong et al., 2011). This increase served to
both push out molecular indicators of FA toxicity to evaluate
the neuroprotective effect of Res and to evaluate beyond
the physiologically defined concentration levels of FA in the
brain (0.2–0.4mM; Chen et al., 2009) in accordance with the
upper levels of FA concentrations (∼0.5mM) reported in the
hippocampus of AD brains (Tong et al., 2013).
Measurement of Cytotoxicity
Cell viability was determined using the Cell Counting Kit-8
(CCK-8) according to the manufacturer’s instruction. Briefly,
N2a cells were seeded at 1.5 × 104 cells/well in a 96-well
plate (Corning, U.S.A.) and cultured for 24 h to allow cell
adhesion. Subsequently, the medium was replaced with FBS-
free DMEM/F12 and cells were respectively treated with FA
(0.1–0.9mM), Res (2.5–50µM), DMSO (0.1–0.5%,) for 24 h. To
investigate whether Res could attenuate FA-induced cytotoxicity,
cells were also pre- and post-treated with Res (0.1–10µM) for
30min before and after 24 h FA (0.35mM; LD50; Figure 1A)
exposure as well as treated simultaneously with 0.35mM FA
for 24 h. The optical absorbance at 450 nm was measured on
a spectrum plate reader (Synergy H1, BioTek, U.S.A.) and cell
viability was expressed as the percentage of viable cells relative to
untreated control cells.
To observe cellular morphology changes, cells (1.5 × 105
cells/well) were seeded in a 12-well plate and after a 24 h
attachment period the cells were treated with Res (0.1–10µM)
for 30min followed by a 4 h FA (0.5mM) exposure. The cells were
fixed with 4% paraformaldehyde (PFA) for 10min and observed
with a Fluorescent Cell Imager (ZOE, Bio-Rad, U.S.A.).
Cell apoptosis was detected with an Annexin-V/PI Staining
Kit according to the manufacturer’s instructions. Briefly, cells
(1.5 × 105) were seeded in a 12-well plate, after treatment with
Res (0.1–10µM, 30min) and FA (0.5 mM, 4 h), cells were
digested with 0.25% EDTA-free Typsin. The cells were then
collected and washed with cold phosphate-buffered saline (PBS).
After washing, the cells were re-suspended in 500µl of binding
buffer containing 5µl Propidium Iodide (PI) and 5µl Annexin
V-FITC, and incubated for 15 min at room temperature in the
dark. Cells were then quantitatively analyzed by Flow cytometer
(Influx, BD, U.S.A.). Ten thousand cells were counted one time
for each sample. The apoptosis rate was analyzed using the Flowjo
7.6.1 (FlowJo, LLC, U.S.A.) software. The following controls were
used to set up compensation and quadrants: (1) unstained cells,
(2) cells stained with FITC Annexin V (no PI), and (3) cells
stained with PI (no FITC Annexin V). The unstained cells (cells
without any treatment) were used to measure the forward scatter
(FSC) and side scatter (SSC) signals, which were used to find
viable cells and remove signals for debris and dead cells. Cellular
debris was considered FSC-low and dead cells were considered
to have low FSC and high SSC. A gate was set to exclude
debris and dead cells from the analysis by drawing polygons
that included the events with high FSC and low SSC (viable
cells). Once the gate was set, viable cells with either FITC or
PI single staining were measured to generate the FITC positive
(vertical axis) or PI positive (horizontal axis) lines, respectively.
The boundary of each line was referenced to the unstained viable
cells. These two parameters were used to produce a bivariate
histogram, which divided the plot into the four quadrants
displaying the four possible combinations: double positive (Q2,
Annexin V+/PI+, late apoptotic cells), single positive for each
dye (Q1, Annexin V−/PI+, necrotic or mechanically damaged
cells; Q3, Annexin V+/PI−, early apoptotic cells), and negative
for both (Q4, Annexin V−/PI−, non-apoptotic cells). The four
quadrant gates were then applied to the other samples to quantify
the percentage of apoptotic cells. The cell apoptotic rate was
calculated as Q2+Q3.
Western Blotting Assays
For western blotting assays, cells were seeded at 1.5 × 105
cells/well in a 12-well plate and were pre- and post-treated
with 10µM Res for 30 min before and after 4 h FA (0.5mM)
treatment as well as simultaneously treated with 10µM Res
and 0.5mM FA. Moreover, pre-treatments of 0.1–10µM Res for
30 min before 4 h FA (0.5mM) exposure were also performed.
Western blotting procedures were performed as described in
the literature (Lu et al., 2013) with small modifications. Briefly,
whole-cell lysates were prepared by incubation of cells in RIPA
buffer supplemented with protease inhibitor cocktail according
to the manufacturer’s instructions. The protein content was
determined using a BCA protein assay kit. Then samples (20µg
of protein) were mixed with loading buffer, heated at 98◦C for
10min, separated on 12% SDS-PAGE gels, and transferred to
PVDF membranes. After blocking with 5% skim milk for 1 h, the
membranes were incubated with primary antibodies (β -actin,
1:5000; Tau5, 1:2500; pT181, 1:4000; GSK-3β , 1:1000; GSK-3β
(Ser-9, phosphor-Serine 9), 1:1000; GSK-3β (Y216, phosphor-
tyrosine 216), 1:250; CaMKII, 1:5000; PP2A, 1:1000) at room
temperature for 1.5 h or at 4◦C overnight. The membranes
were then washed three times with TBST for 10min each,
followed by incubation with the corresponding anti-rabbit/anti-
mouse IgG horseradish peroxidase (HRP)-conjugated secondary
antibodies (1:5000) at room temperature for 1 h. The membranes
were again washed three times with TBST (10min each time)
and visualized with chemiluminescent HRP substrate according
to the manufacturer’s instructions. Luminescence was captured
in the ImageQuant LAS 4000 digital imaging system (GE
Healthcare Bio-Sciences, Pisacataway, U.S.A.). The individual
band intensities were quantified with the Image J software
package (National Institute of Health, Besthada, U.S.A.) and
normalized to the intensity of β-actin bands. This allowed
individual bands to be compared to the total protein on each
membrane. The quantification of GSK3β-Y216 band intensity
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FIGURE 1 | Protective effect of Resveratrol (Res) against formaldehyde (FA)-induced cytotoxicity in N2a cells, including the respective effect of FA (A),
Res (B), and DMSO (C) on the viability of N2a cells. N2a cells were treated with FA (0.1–0.9mM), Res (2.5–50 µM), and DMSO (0.1–0.5%) alone for 24 h. Then cell
viability was detected with a CCK-8 assay. The protective effect of Res against FA-induced cytotoxicity was investigated in N2a cells. N2a cells were pre-treated (D) or
post-treated (E) with Res (0.1, 1, 2.5, 5, and 10µM) for 30min before or after FA exposure for 24 h, or treated simultaneously (F) with 0.35 mM FA for 24 h. Cell
viability was detected with a CCK-8 assay. All data are presented as the mean ± SEM from independent experiments performed in triplicate (n = 3). **p < 0.01,
***p < 0.001 compared to control group. ###p < 0.001 vs. FA treatment group.
was measured as the total of all bands, as per a previous study
of GSK3β post-translational measurements (Beurel et al., 2015).
The intensity of the lowest band alone was also quantified.
Immunofluorescence Assays
Immunofluorescence assays were performed to further confirm
the presence of phosphorylated tau (pT181) and related enzymes
according to a previously established protocol (Wei et al., 2016).
In brief, cells were seeded at 1.5 × 104 cells/well on sterile
coverslips placed in 24-well culture plates. Cells were pre-treated
with 10µM Res for 30 min before a 0.35 mM FA treatment
for 4 h. After treatment, cells were washed three times with
PBS (5 min each time) and fixed with 4% PFA for 20min at
4◦C, then permeabilized with 0.4% Triton X-100 for 30 min at
room temperature. The coverslips were then blocked with 5%
bovine serum albumin (BSA) for 1 h, followed by an incubation
in 1% blocking buffer with primary antibodies (tublin, 1:1000,
pT181, 1:100; GSK-β , 1:1000; GSK-β (Y216), 5µg/ml; GSK-
3β (Ser9), 1:100; CaMKII, 1:250; PP2A, 1:250; Tau2, 1:500) at
4◦C overnight. Cells were washed three times with PBS (5min
each time) to remove residual primary antibodies. Cy5-labeled
Donkey anti-Rabbit/Donkey anti-Mouse secondary antibodies
(1:200) were added and allowed to bind at 37◦C for 1 h in
the dark. The coverslips were then washed as mentioned earlier
and were incubated with DAPI (1:1000) for 10min in the
dark. Following three 5-min washings with PBS, the slides were
mounted with 90% glycerol (Solarbio, China), then sealed with
nail polish. Slides were observed under a laser scanning confocal
microscope (A1MP+, Nikon, Japan).
Statistical Analysis
Cell viability and western blot data analysis were conducted
using the SPSS software package (SPSS Inc., Chicago, IL,
U.S.A.). The normality of the data was determined using the
Kolmogorov-Smirnov test. All the data were normally distributed
(Kolmogorov-Smirnov tests: all p > 0.05) and were analyzed by
one-way ANOVA. The alpha level was set at p = 0.05 and all
p-values were generated using two-sided tests. Tukey’s tests were
used for post-hoc comparisons. Results were calculated over at
least three independent experiments and were presented as the
mean± SEM (standard error of the mean).
RESULTS
Neuroprotective Effects of Res against
FA-Induced Cytotoxicity
Slow progressive neuronal death is a major characteristic of AD
(Shimohama, 2000). In this study, the protective effect of Res
against FA-induced neuronal toxicity was studied in N2a cells.
FA induced cell death in a dose-dependent manner with an
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LD50 of ∼0.35 mM (Figure 1A). Data from the CCK-8 assays
showed that Res alone (2.5–50µM) did not cause any loss
of N2a cell viability after 24 h treatments (Figure 1B). Similar
results were observed when N2a cells were treated with different
concentrations of DMSO (0.1–0.5%), the vehicle used for Res
(Figure 1C). To determine whether Res attenuates FA-induced
cytotoxicity, cell viability assays were performed with pre- and
post-treatments of Res (0.1–10µM) for 30min, as well as with
simultaneous-treatments of Res, with FA for 24 h. Pre-treatment
with Res dose-dependently attenuated FA-induced cytotoxicity
(Figure 1D), with a significant effect observed at a concentration
of 2.5µM (p = 6.728 × 10−5). The viability of N2a cells was
not influenced by post-treatments (Figure 1E, p = 0.497) or
simultaneous-treatments (Figure 1F, p= 0.371) of Res.
In addition, an Annexin V-FITC/PI double staining assay was
used to briefly evaluate the respective effect of FA and Res on N2a
cell apoptosis. The experiments found that 0.5mM FA increased
the apoptotic rate to 32.7% in comparison to the control group
(0.9%) (Figure 2). However, pre-treatment with Res (0.1, 1, 2.5,
5, and 10µM) given prior to FA (0.5 mM) exposure decreased
the percentage of apoptotic cells to 14.5, 14.4, 11.6, 10.2, and
6.9%, respectively (Figure 2). These results were consistent with
the findings from the cell viability assays, and, together, showed
that pre-treatment of Res protected N2a cells against FA-induced
cytotoxicity.
Cellular morphology was also observed using a microscope
at different magnifications. Compared with controls, FA-treated
cells were smaller and atrophied with irregular cell borders
and reduced cellular processes, while cells pre-treated with Res
showed a higher cell density and a more natural cell morphology.
Moreover, cell neurites were partially retained in comparison
with cells treated with FA alone (Figure 3).
In consideration of the functions of the tau protein to
promote the assemble of microtubules and maintenance of the
microtubule system in neurons (Drechsel et al., 1992; Götz
et al., 2006), as well as findings that abnormal phosphorylation
of tau protein leads to microtubule disassembly, cytoskeleton
destabilization and eventually cell death (Iqbal et al., 2005), it was
hypothesized that the protective effect of Res against FA-induced
neurotoxicity andmorphological changes was likely related to the
modulation of tau protein phosphorylation.
Effects of Res on FA-Induced Tau Protein
Hyperphosphorylation
Previous studies indicated that FA triggered abnormal tau protein
hyperphosphorylation in vitro and in vivo (Nie et al., 2007; Lu
et al., 2013). In this study, tau protein hyperphosphorylation at
Thr181 (p = 6.965 × 10−9) and Ser396 (p = 2.750 × 10−7)
were significantly increased after treatment with 0.5mM FA
(Figure 4A). Pre-treatment with 10µMRes significantly reduced
FA-induced tau phosphorylation at Thr181 (p = 7.456 × 10−9),
but not at the Ser396 site, which did not change significantly (p=
1.000). As in the cell viability and apoptosis studies above, post-
(p= 0.930 for Thr181 and p= 0.991 for Ser396) or simultaneous-
treatment (p = 0.994 for Thr181 and p = 1.000 for Ser396) of
10µM Res did not influence tau phosphorylation levels at either
the Thr181 or Ser396 loci (Figure 4A). It was further elucidated
that pre-treatment with 0.1–10µM Res reduced FA-induced tau
hyperphosphorylation at Thr181 in a dose-dependent manner
(p = 0.007 at 1µM of Res; Figure 4B). The expression level of
total tau protein did not show a significant change with (p =
0.979 at 10µM of Res) or without (p = 0.321) Res treatment
(Figure 4B), which indicated an overall net effect of Res that
suppressed FA induced tau protein hyperphosphorylation. All
told, these results suggested that Res significantly inhibited tau
protein hyperphosphorylation at Thr181, but not at Ser396, in a
dose-dependent manner.
Effects of Res on Kinase (GSK3β/CaMKII)
Inactivation and Phosphatase (PP2A)
Activation
Kinases and phosphatases, such as glycogen synthase kinase
(GSK-3β), calmodullin-dependent protein kinase II (CaMKII)
and phosphoseryl/ phosphothreonyl protein phosphatase-2A
(PP2A), are important enzymes involved in the regulation of
hyperphosphorylation of tau protein in the development of
AD (Gong et al., 1993, 1995; Pei et al., 1999; Vogelsberg-
Ragaglia et al., 2001; Wang et al., 2005). In the present study,
the effects of Res on the regulation of GSK-3β, CaMKII, and
PP2A activities were investigated. It was found that the level
of phosphorylation on GSK-3β at Y216 (activation site) was
significantly increased after treatment with 0.5mM FA for 4 h
(p = 1.974 × 10−5; Figure 5), while phosphorylation at Ser9
(inhibition site) did not exhibit a significant change (p = 1.000).
This suggested an increased activity of total GSK-3β (p = 0.005).
Conversely, pre-treatment with Res significantly decreased the
level of phosphorylation on GSK-3β at Y216 (p= 1.722× 10−4 at
2.5µM of Res). This indicated that the phosphorylation of GSK-
3β at the activation site was inhibited by Res treatment (Figure 5).
However, phosphorylation of GSK-3β at the Ser9 site was not
found to change significantly with Res pre-treatment prior to FA
exposure (Figure 5, p= 0.997 at 10µM of Res).
An analogous result was found with CaMKII. The protein
level of CaMKII was significantly increased under FA stress
(p = 0.002), while pre-treatment with Res significantly reduced
the level of CaMKII in a dose-dependent manner (Figure 5, p =
0.005 at 1µM of Res).
With respect to the phosphatase PP2A, a significantly decrease
in the protein level of PP2A was found after FA exposure
(p = 0.008), while pre-treatment with Res significantly increased
the protein levels (Figure 5, p = 0.020 at 1µM of Res). These
results suggest that Res protects N2a cells from FA-induced
tau protein hyperphosphorylation by decreasing the activities
of GSK-3β and CaMKII as well as increasing the activity of
PP2A. Interestingly, no significant changes on the regulation
of GSK-3β , CaMKII and PP2A activities and/or expression
were found after 30min of Res treatment alone (data not
shown).
Alterations to tau protein hyperphosphorylation, kinase,
and phosphatase levels and protein localizations were further
investigated by immunofluorescence staining. An increased
staining signal of tau (pT181), GSK-3β, and CaMKII as well
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FIGURE 2 | Protective effect of Res against FA-induced cell apoptosis. N2a cells were pre-treated with Res (0.1, 1, 2.5, 5, and 10µM) for 30min and then
treated with 0.5mM FA for 4 h. Cell apoptosis rates were measured with Annexin-V/PI double staining. A single apoptotic assay was performed with 10,000 cells
quantitatively analyzed per group in a Flow cytometer. The Annexin V-FITC vs. Propidium Iodide (PI) gates denote the following populations: necrotic or mechanically
damaged cells (Q1, Annexin V−/PI+), late apoptotic cells (Q2, Annexin V+/PI+); early apoptotic cells (Q3, Annexin V+/PI−) and non-apoptotic cells (Q4, Annexin
V−/PI−). The cell apoptotic rate was calculated as Q2+Q3.
FIGURE 3 | Protective effect of Res against FA-induced cell morphological changes. N2a cells were pre-treated with Res (0.1, 1, 2.5, 5, and 10µM) for
30min, and then treated with 0.35mM FA for 4 h. Cell morphology was observed using a microscope at different magnifications (upper bar: 100µm; lower bar:
30µm). The images show morphological changes of cells with or without Res treatment.
as a decreased staining pattern of PP2A were detected after
FA treatment (Figure 6). These staining patterns were also
ameliorated with pre-treatments of Res and were consistent with
the findings of the Western blot analysis.
DISCUSSION
In this study, FA exposure was observed to induce ADmarkers in
vitro, including tau protein hyperphosphorylation and neuronal
Frontiers in Neuroscience | www.frontiersin.org 6 January 2017 | Volume 10 | Article 598
He et al. Resveratrol Attenuates Formaldehyde-Induced Tau Hyperphosphorylation
FIGURE 4 | Res attenuates FA-induced tau protein hyperphosphorylation in N2a cells. (A) N2a cells were pre-treated or post-treated with 10µM of Res for
30min before or after 0.5mM FA exposure for 4 h, or treated simultaneously with 0.5 mM FA for 4 h. (B) N2a cells were pre-treated with Res (0.1, 1, 2.5, 5, and
10µM) for 30min, and then treated with 0.5 mM FA for 4 h. Total and phosphorylated tau protein levels were determined by Western blotting (A,B). Densitometry
values were calculated from independent experiments performed in triplicate (n = 3) and presented as mean ± SEM. *p < 0.05, ***p < 0.001 vs. control. ##p < 0.01,
###p < 0.001 vs. FA treatment group.
death. Pre-treatment with Res was found to significantly decrease
FA-induced cytotoxicity, to reduce cellular apoptosis rates and
to inhibit tau protein hyperphosphorylation. It was further
revealed that Res protected the cells from FA-induced damage by
modulating the activities of GSK-3β , CaMKII kinase, and PP2A
phosphatase.
As AD is a global health problem that is accelerating its
reach with an increasingly aging population (Gong, 2014), it
has become urgent to develop new therapies for successful
prevention and management of this chronic debilitating disease.
In recent studies, it has been implicated that FA is one of the
factors involved in the initiation and progression of AD (Kilburn
et al., 1987; Nie et al., 2007; Tong et al., 2011, 2013; Lu et al., 2013;
Rizak et al., 2014), which suggests that new therapies may be
developed for the treatment of AD by protecting neurons against
FA-induced damages.
Res, a polyphenol anti-oxidant, was observed in this study
to protect N2a cells against FA-induced cytotoxicity and tau
protein hyperphosphorylation. It was further identified that the
neuroprotective effect of Res was related to a signaling cascade
which modulated the activities of kinases and a phosphatase
involved in tau protein phosphorylation. FA was also found to
induce cell morphological changes and cell apoptosis in this
and other studies (Lu et al., 2013). In the present study, pre-
treatment with Res was demonstrated to protect N2a cells against
FA-induced cytotoxicity by increasing cell viability, decreasing
cell apoptotic rates and maintaining cell morphology. This
protective effect was found to occur in a dose-dependent manner
with significant effects observed at concentrations of 2.5µM or
greater. Although this concentration was 140 times lower than
that of FA (0.35 mM), the pre-treatment of Res was sufficient to
protect the N2a cells from FA-induced damages. Simultaneous-
or post-treatments of Res did not protect or improve damage to
the cells, which is in accordance with the findings from a previous
study where simultaneous treatments of equal doses of Res and
FA (such as 100µM) did not reverse FA-induced cytotoxicity
(Marcsek et al., 2007). In the case of this study, the concentration
of FA was much higher than Res, which suggested the ability of
Res to capture FA directly may be overshadowed. The results and
concentrations in this study suggested that the protective effect
of Res against FA-induced cytotoxicity was mediated through a
signaling cascade, rather than the direct interaction of Res, as a
natural formaldehyde capturer (Tyihák et al., 1998), with FA.
It was then hypothesized that Res exerted this protective effect
by regulating the phosphorylation state of tau protein because
abnormal tau protein hyperphosphorylation can result in the
disassembly and depolymerization of microtubules leading to
cell death (Obulesu et al., 2011; Duan et al., 2012). In this
study, a significantly increased tau protein hyperphosphorylation
at Thr181 and Ser396 was observed after FA treatment, which
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FIGURE 5 | Res down-regulated the level of GSK-3β and CaMKII and up-regulated the level of PP2A. N2a cells were pre-treated with Res (0.1, 1, 2.5, 5, and
10µM) for 30min, and then treated with FA (0.5mM) for 4 h. Cells were collected and the protein levels of GSK-3β , CaMKII and PP2A were detected by Western blot
analysis. Densitometry values were calculated from independent experiments performed in triplicate (n = 3) and presented as mean ± SEM. **p < 0.01, ***p < 0.001
vs. control. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. FA treatment group.
was consistent with previous studies (Nie et al., 2007; Lu
et al., 2013). Pre-treatment with Res significantly inhibited
FA-induced tau phosphorylation at Thr181 at a relatively
low dosage (2.5µM). This suggests that Res protects N2a
cells against FA-induced neurotoxicity through inhibiting tau
protein hyperphosphorylation. Interestingly, pre-treatment of
Res influenced FA-induced tau phosphorylation at Thr181 but
not at Ser396, which suggested that this protective effect was
site-specific.
The hyperphosphorylation of tau protein is regulated by
phosphorylation of a number of kinases (such as GSK-3β and
CaMKII) and the dephosphorylation activity of a phosphatase
(PP2A) (Wang et al., 2007). To further elucidate the role of Res
in reducing FA-induced tau protein hyperphosphorlation, the
protein levels of these enzymes and the phosphorylation state of
GSK-3β were investigated in this study. It was found that the
phosphorylation of GSK-3β at Y216 site (activated form) was
increased after FA treatment, while the phosphorylation at Ser9
site (inactivated form) did not change significantly. This suggests
that GSK-3β activation contributed to the hyperphosphorylation
of tau protein, which is similar to a previous study that
demonstrated FA triggered tau protein hyperphosphorylation via
GSK-3β signaling (Lu et al., 2013).
This study also demonstrated that the level of CaMKII was
elevated after FA exposure. CaMKII is considered a tau protein
kinase that can augment the subsequent phosphorylation of
tau catalyzed by GSK-3β (Wang et al., 1998). Furthermore,
FA toxicity induced a decrease in the protein level of PP2A,
which has been found to dephosphorylate most abnormal
phosphorylation sites on tau protein (Ono et al., 1995; Wang
et al., 1995, 1996). These results suggested that the neurotoxic
effects of FA were caused, at least in part, by the increased
activities of GSK-3β and CaMKII and decreased activity of PP2A.
RNA interference experiments with GSK-3β specific siRNA
alone did not reduce tau phosphorylation to constitutive levels
after FA administration (Lu et al., 2013), further suggesting
that FA imparts its toxicity through a number of signaling
mechanisms.
Frontiers in Neuroscience | www.frontiersin.org 8 January 2017 | Volume 10 | Article 598
He et al. Resveratrol Attenuates Formaldehyde-Induced Tau Hyperphosphorylation
FIGURE 6 | Immunofluorescence staining of N2a cells labeled for phosphorylated tau protein (Thr181), GSK-3β (total and Ser9/Y216 site), CaMKII, and
PP2A (Bar: 20µm). N2a cells were pre-treated with 10µM Res for 30min and then treated with FA (0.5mM) for 4 h. Fixed cells immunostained as labeled were
observed for changes in the fluorescence of phosphorylated tau (Thr181, red), GSK-3β (total and Ser9/Y216 site, red), CaMKII and PP2A (red), DNA (DAPI, blue), and
cytoskeleton (Tubulin, green) by fluorescence confocal microscopy. Each test was repeated three times and 10 cells/coverslip were imaged for each repeat.
In order to determine whether the inhibitory effect of
Res on tau protein hyperphosphorylation was due to the
modulation of these enzymes, the protein levels of the candidate
enzymes mentioned above were investigated following pre-
treatment with Res. Consistent with the suppressive effect of Res
on tau protein hyperphosphorylation, pre-treatment with Res
significantly inhibited FA-induced increasing phosphorylation
of GSK-3β and CaMKII protein level. This indicated that
regulation of these two kinases is important in the attenuation
of FA-induced hyperphosphorylation of tau protein by Res. In
addition, it was found that pre-treatment of Res significantly
increased the protein level of PP2A where FA exposure was
found to down-regulate PP2A levels. This suggests that PP2A
may also be involved in the neuroprotective effect of Res
against tau protein hyperphosphorylation. All these results
indicate that Res inhibited tau protein hyperphosphorylation
by regulating the activities of GSK-3β, CaMKII and PP2A,
all of which are important enzymes known to modulate the
homeostasis of tau protein phosphorylation (Wang et al.,
2007).
Interestingly, Res treatments alone were not found to
modulate the baseline levels of the enzymes GSK-3β, CaMKII,
and PP2A in the 30min prior to the addition of FA (data
not shown). This is a complicated result that suggests that the
neuroprotective effect of Res against FA toxicity either works
upstream through an unknown mechanism to prime the cells
against toxic insults or that the effects of Res manifest after the 30
min incubation period. Further investigation into the up-stream
modulation of these signaling pathways, both in relation to toxic
insult and Res neuroprotection, may uncover new knowledge
applicable to the treatment of Alzheimer’s disease.
In summary, the present study provided the first evidence that
Res exerts a significant neuroprotective effect on N2a cells against
FA-induced damages through the inhibition of tau protein
hyperphosphorylation. The molecular mechanisms behind this
inhibition is likely related to the modulation of GSK-3β, CaMKII
and PP2A activities. Taken together, this study extended our
understanding of the neuroprotective effects of Res and suggested
that Res modulates a number of enzymes specifically involved
in the regulation of tau protein hyperphosphorylation, which
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is considered an important drug target in the treatment of AD
pathology.
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